Patents Examined by Jeffrey T Palenik
  • Patent number: 11826449
    Abstract: A method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors are described. The composition has a retinoic acid precursor and a resorcinol to impede oxidation of the precursor in situ in the composition.
    Type: Grant
    Filed: April 5, 2022
    Date of Patent: November 28, 2023
    Assignee: Conopco, Inc.
    Inventors: Anjing Lou, Teanoosh Moaddel, Anil Babubhai Patel
  • Patent number: 11801219
    Abstract: A pouch product comprising a sealable pouch material comprising i) 0 to 10 wt % Cannabis, ii) 0 to 10 wt % nicotine, whereby nicotine is present in the form of iia) tobacco or iib) as nicotine pure and as nicotine salicylic acid salt at a ratio of pure to salt of 0.20-1:1, and up to of one or more 100 wt % of iii) a sweetener, iv) a pH regulator, and v) essential oil as taste agent. The filling material further comprises vi) up to 76 wt % of a filler consisting of vi-1) 42 to 60 wt % microcrystalline cellulose and vi-2) 11 to 22 wt % potato fibers, at a ratio of 2.0-5:1, and vii) 0.1 to 5 wt % of xanthan gum as a wetting agent, whereby the ratio between microcrystalline cellulose, potato fibers and xanthan gum is 1.0-5:1:0.001-0.4.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: October 31, 2023
    Inventor: Evaggelos Schjölin
  • Patent number: 11793735
    Abstract: An aluminum-free antiperspirant/deodorant composition is disclosed. The antiperspirant/deodorant may include an oil-in-water emulsion base and an antiperspirant active dispersed in the oil-in-water emulsion base. The antiperspirant active may be primarily a zinc-based antiperspirant active and the oil-in-water emulsion base may include an emulsifier comprising a mixture of steareth-2 and steareth-20; a plant-based oil, a polyol, and water.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: October 24, 2023
    Assignee: Colgate-Palmolive Company
    Inventors: Peter Hilliard, Jr., Sharon Kennedy, Cristina Bielli, Richard Adams
  • Patent number: 11766452
    Abstract: An improved aqueous teat dip comprising iodine and chlorhexidine in an aqueous solution.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: September 26, 2023
    Assignee: Webco Chemical Corporation
    Inventor: Michael J. Loosemore
  • Patent number: 11752106
    Abstract: The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.
    Type: Grant
    Filed: September 15, 2021
    Date of Patent: September 12, 2023
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Eleni Dokou, Shahla Jamzad, John P. Caesar, Jr., Majed Fawaz, Laura Das, Chong-Hui Gu, Patricia Nell Hurter, Meghna Jai Israni, Meghan M. Johnston, Dragutin Knezic, Andrew G. Kuzmission, HongRen Wang
  • Patent number: 11738041
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Grant
    Filed: April 19, 2022
    Date of Patent: August 29, 2023
    Assignee: RENOSIS, INC.
    Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
  • Patent number: 11730852
    Abstract: Disclosed herein are embodiments of a wound care material with a material which is a composite of a matrix component comprising a flexible hydrophilic polymer foam or fiber matrix comprising two matrix faces providing a release face and a reverse face or two release faces, and therebetween a structural matrix framework defining a network of cells having a cell network surface and therein a network of pores or cell openings, and a powder charge component comprising antimicrobial additive or wound care additive, wherein said powder charge is comprised at one said release face or both said faces and/or within said cell network.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: August 22, 2023
    Assignee: Smith & Nephew PLC
    Inventors: Amy Brewster, Robert Crump, Helene Anne Lecomte, David Stephenson, Matthew Wray
  • Patent number: 11701362
    Abstract: Provided are formulations and dosage forms of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide, alternatively named (1s,4s)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide, or a pharmaceutically acceptable salt, tautomer, solvate, hydrate, co-crystal, clathrate, or polymorph thereof.
    Type: Grant
    Filed: December 22, 2020
    Date of Patent: July 18, 2023
    Assignee: Celgene Corporation
    Inventors: Scott Bone, Tracy Lee Gaebele, Yu Pu, Lianfeng Huang
  • Patent number: 11690886
    Abstract: The present invention relates to the combination of a retinoid and an extract of Silybum marianum (L.) Gaertn., the dermatological and dermocosmetic compositions containing such a combination, as well as their uses as a medicinal product, in particular in the treatment of acne, seborrhea, seborrhoeic dermatitis and/or rosacea.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: July 4, 2023
    Inventors: Jean-Hilaire Saurat, Olivier Sorg
  • Patent number: 11660313
    Abstract: Disclosed herein are compositions that can form a covering, layer, film, device, and/or prosthetic skin that can be comfortably worn to provide skin barrier function, skin hydration and therapeutic and aesthetic benefits. The present invention provides novel compositions that have low tackiness and form quickly, resulting in a wearable, comfortable (maintains temperature and humidity), breathable, thin, optically invisible, cosmetically elegant, flexible, stretchable, elastic and body-movement conforming, yet long-lasting covering, layer, film, device, and/or prosthetic skin on the skin or any other body surface. The present invention provides novel compositions that can form a covering, layer, film, device, and/or prosthetic skin that works for extended periods in excess of about 24 hours, while retaining function during and after exercising, showering and swimming (in sea-water, fresh water and chlorinated water), steam room (heat at high humidity), and sauna (heat at low humidity).
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: May 30, 2023
    Assignee: Shiseido Company, Limited
    Inventors: Ariya Akthakul, Nithin Ramadurai, Amir Nashat, Daniela Beccati, Melaney Bouthillette
  • Patent number: 11590075
    Abstract: The present disclosure relates to methods and products for reducing adhesions. In certain embodiments, the present disclosure provides a method of reducing adhesions in a subject, the method comprising exposing a region in the subject susceptible to formation of an adhesion to an agent having iron chelation and/or antioxidant activity, thereby reducing adhesions in the subject.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: February 28, 2023
    Assignee: The University of Adelaide
    Inventors: Sarah Vreugde, Peter John Wormald
  • Patent number: 11584828
    Abstract: Polyphosphazenes polyelectrolytes. The polyphosphazenes can be prepared by substituting pendant groups (e.g., ionic groups or pendant groups that can form ionic groups) onto a reactive macromolecular precursor for example, by reaction between the reactive chlorine atoms on the backbone of poly(dichlorophosphazene) and appropriate organic nucleophiles. In certain examples, one or more charged pendant groups of a polyphosphazene is/are further modified to introduce desired counterions, which can be hydrophobic counterions. The polyphosphazenes can activate distinct Toll-Like Receptors (TLRs) and can be used in methods of stimulating an immune response.
    Type: Grant
    Filed: December 3, 2020
    Date of Patent: February 21, 2023
    Assignee: University of Maryland, College Park
    Inventors: Alexander K. Andrianov, Thomas R. Fuerst, Peter Fusco, Alexander Marin
  • Patent number: 11576378
    Abstract: Self-indicating chemistries are provided for visual detection by a user of efficacious levels of peroxycarboxylic acid concentrations in a solution produced in situ. The self-indicating chemistries include a combination of dyes providing a visual color indication, such as a tri-color indicator system, such as a yellow, green, and red color system indicating in situ threshold levels of peroxycarboxylic acid concentrations in a solution employing the self-indicating chemistry. Systems, kits and compositions for a quantitative assessment of an in situ perhydrolysis reaction to generate peroxycarboxylic acids are provided. Methods of use are further provided.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: February 14, 2023
    Assignee: Ecolab USA Inc.
    Inventors: David D. McSherry, Junzhong Li, Richard Staub
  • Patent number: 11553718
    Abstract: The invention relates to a process for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation. The invention further relates to the use of a water soluble source of lithium ions for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation.
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: January 17, 2023
    Assignee: Omya International AG
    Inventors: Anita Zumsteg, Joachim Glaubitz, Simon Urwyler, Matthias Buri, Patrick A. C. Gane
  • Patent number: 11541129
    Abstract: Disclosed herein are biomaterial implants, medical devices, or bioprostheses wherein a surface or part thereof is coated with a nanoreservoir comprising a hydrophilic polymer or copolymer backbone crosslinked to a second polymer comprising a hydrophilic backbone and one or more reactive moieties, wherein the nanoreservoir further comprises one or more bioactive molecules, therapeutic molecules, or drugs.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: January 3, 2023
    Inventors: Cécile Oury, Christine Jérôme, Christophe Detrembleur, Patrizio Lancellotti
  • Patent number: 11534395
    Abstract: A suspension includes an ophthalmic active ingredient suspended in a formulation vehicle including a suspending agent and a non-ionic cellulose derivative. The ophthalmic active agent is present as particles having Dv90<5 ?m and Dv50<1 ?m. The suspension may be administered to a patient for treating an ophthalmic inflammatory condition.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: December 27, 2022
    Assignee: Bausch & Lomb Incorporated
    Inventors: Mohannad Shawer, Eric Phillips, Martin J. Coffey
  • Patent number: 11523986
    Abstract: Disclosed herein are compositions including diphenhydramine, or a pharmaceutically acceptable salt thereof, and a liquid vehicle. The compositions may be administered intranasally to patients in need of diphenhydramine. The compositions provide increase plasma and brain concentrations relative to orally administered compositions, but without the limitations associated with intravenously administered compositions.
    Type: Grant
    Filed: March 19, 2020
    Date of Patent: December 13, 2022
    Assignee: DBBH, LLC
    Inventors: John Sramek, Anthony R. DiSanto
  • Patent number: 11517562
    Abstract: The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.
    Type: Grant
    Filed: June 1, 2022
    Date of Patent: December 6, 2022
    Assignee: XSPRAY PHARMA AB
    Inventors: Magnus Brisander, Mustafa Demirbüker, Gérald Jesson, Martin Malmsten, Helene Dérand
  • Patent number: 11517519
    Abstract: The present invention relates to a process for treating human keratin fibres such as the hair, which comprises: i) a step of applying to the human keratin fibres a composition comprising: —at least one plant wax: —at least 60% by weight of water relative to the total weight of the composition; ii) followed by a step of heating the keratin fibres by means of a heating appliance at a temperature ranging from 80° C. to 160° C., preferably from 110° C. to 50° C., more preferably from 120° C. to 150° C., which is moved along the fibres, iii) optionally followed by a step of rinsing the keratin fibres.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: December 6, 2022
    Assignee: L'OREAL
    Inventors: Eric Parris, Gabin Vic, Frédéric Woodland
  • Patent number: 11504336
    Abstract: An extended release pharmaceutical composition of Clozapine The extended release composition of Clozapine provides an extended release pharmaceutical composition having Clozapine, a seal coating, an acidic coating, and an extended release coating. The composition is particularly suitable for dispensing a once-a-day solid oral pharmaceutical formulation which releases a therapeutically effective amount of Clozapine over an extended time period.
    Type: Grant
    Filed: September 16, 2017
    Date of Patent: November 22, 2022
    Inventors: Mayank Saxena, Rikin Patel, Piyush Kansagra, Balvir Singh, Ashish Sehgal